Bausch & Lomb CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Bausch + Lomb updates its proxy statement to reflect agreements between its majority shareholder, Bausch Health Companies Inc., and certain shareholder groups regarding board representation and voting.
NYSE
Bausch + Lomb achieved impressive results in 2024, marked by 16% reported revenue growth and a 17% constant currency revenue increase, driven by successful product launches and leadership in key categories.
NYSE
Bausch + Lomb Corporation will hold its 2024 Annual Meeting of Shareholders virtually on May 29, 2024, to vote on director elections, executive compensation, an incentive plan amendment, and auditor appointment.